This physician role focuses on medical leadership and monitoring for two pivotal phase 3 clinical programs in AML and broader hematologic malignancies. The work combines strategic clinical development input with hands-on medical monitoring as part of an active drug development team. It is suited to a physician who can work independently while helping guide program direction.
Key Responsibilities
- Provide medical leadership across phase 3 clinical development programs
- Conduct hands-on medical monitoring for ongoing studies
- Support strategic direction for clinical trial programs
- Collaborate with a high-performing team during active clinical development
- Review and monitor studies in AML and broader hematologic malignancies
- Work independently with minimal oversight while contributing to program decisions
Required
- Physician qualification
- Experience in AML or broader hematologic malignancies
- Demonstrated leadership of phase III clinical studies
- Ability to serve as both clinical development lead and medical monitor
- Ability to work independently with minimal oversight